GMX Reliance Gen.

RNS Number:7264J
GeneMedix PLC
12 December 2007


FOR IMMEDIATE RELEASE                                        12th December 2007


                                 GeneMedix plc

                       Changes to the Board of Directors

GeneMedix plc ("the Company"), the AIM listed biopharmaceutical company,
subsequent to its press release on 30 November 2007, announces further details
on the move of its headquarters to Ireland.

The Board has been discussing the merits of consolidating the Company's
operations in Ireland now that there are no other overseas operations in the
GeneMedix plc Group. The infrastructure and resources available in Ireland have
been expanded significantly over the past year, and it is now felt that the
integration of the Company with Reliance Life Sciences (RLS) is sufficiently
advanced that the Company's operations can be better managed from Ireland. As a
result the decision has been made by the Board to proceed with the consolidation
with immediate effect, and for it to be completed by 15 January 2008.

Discussions are on-going with senior executives at the Company about supporting
the business during the relocation period but it is unlikely, due to personal
circumstances, that any of the staff based in the Company's head office in
Newmarket will be moving permanently to Ireland.

Julian Attfield, the Company's current CEO and CFO, will not be relocating and
will be leaving the Company and the Board at the end of December 2007, after
which time he will provide assistance to the Company as required.

Commenting on Julian Attfield's impending departure from the Company, Dr Kim
Tan, the Company's Non Executive Chairman, stated:

"Julian leaves the Company at an exciting point in its development and I would
like to thank him on behalf of the Board for his hard work and the contribution
he has made to GeneMedix plc. We wish him well for the future."

Vinay Ranade will take over as CEO of the Company from 1 January 2008 and will
be based at the Company's offices in Ireland. Vinay Ranade, aged 40, is a
Chartered Accountant and a Management Graduate by qualification and has over 17
years of experience in various fields including investment banking, finance and
commercial functions, business, projects and operations. He has been a core team
member in developing the biotechnology initiatives at Reliance Life Sciences
since 2001. He has been associated with the Company during the acquisition
process since December 2005 and has been part of the integration team since that
date.


ENQUIRIES:

GeneMedix plc                                                Tel: 01638 663320
Dr Kim Tan, Non Executive Chairman

Deloitte Corporate Finance                                   Tel: 020 7936 3000
Jonathan Hinton/John Ball

Bankside Consultants                                         Tel: 020 7367 8888
Michael Padley/Susan Scott

ENDS


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BOAUURRRBARUAAA

Reliance Genemedix (LSE:GMX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Reliance Genemedix (LSE:GMX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025